Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation reviews pertinent aspects of both autologous and allogeneic stem cell transplantation and our current understanding of transplantation biology including T cell and natural killer cell biology, HLA expression, and post-transplant immune reconstitution. The uniq...

Full description

Bibliographic Details
Other Authors: Bishop, Michael R. (Editor)
Format: eBook
Language:English
Published: New York, NY Springer US 2009, 2009
Edition:1st ed. 2009
Series:Cancer Treatment and Research
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03840nmm a2200277 u 4500
001 EB000356673
003 EBX01000000000000000209725
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9780387785806 
100 1 |a Bishop, Michael R.  |e [editor] 
245 0 0 |a Hematopoietic Stem Cell Transplantation  |h Elektronische Ressource  |c edited by Michael R. Bishop 
250 |a 1st ed. 2009 
260 |a New York, NY  |b Springer US  |c 2009, 2009 
300 |a XV, 589 p  |b online resource 
505 0 |a Principles and Overview of Allogeneic Hematopoietic Stem Cell Transplantation -- The Principles and Overview of Autologous Hematopoietic Stem Cell Transplantation -- Natural Killer Cell Activity and Killer Immunoglobulin-Like Receptors in Hematopoietic Stem Cell Transplantation -- Advancement and Clinical Implications of HLA Typing in Allogeneic Hematopoietic Stem Cell Transplantation -- Immunogenomics and Proteomics in Hematopoietic Stem Cell Transplantation: Predicting Post-Hematopoietic Stem Cell Transplant Complications -- Clinical Implications of Immune Reconstitution Following Hematopoietic Stem Cell Transplantation -- Functionally Defined T Cell Subsets in Transplantation Biology and Therapy: Regulatory T Cells and Th2 Cells -- Understanding and Enhancing the Graft-Versus-Leukemia Effect After Hematopoietic Stem Cell Transplantation -- Reduced-Intensity and Nonmyeloablative Conditioning Regimens -- Umbilical Cord Blood Transplantation -- Biology and Management of Acute Graft-Versus-Host Disease -- Biology and Management of Chronic Graft-Versus-Host Disease -- Radioimmunoconjugates in Hematopoietic Stem Cell Transplantation -- Evolving Indications for Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Other Plasma Cell Disorders -- Role of Hematopoietic Stem Cell Transplantation in the Treatment of Non-Hodgkin’s Lymphoma -- The Role of Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma -- Role of Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndrome -- Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia -- Hematopoietic Stem Cell Transplantation in Children and Adolescents with Malignant Disease -- Cellular Adoptive Immunotherapy After Autologous and Allogeneic HematopoieticStem Cell Transplantation -- Improvements in the Prevention and Management of Infectious Complications After Hematopoietic Stem Cell Transplantation 
653 |a Hematology 
653 |a Oncology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Cancer Treatment and Research 
028 5 0 |a 10.1007/978-0-387-78580-6 
856 4 0 |u https://doi.org/10.1007/978-0-387-78580-6?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616,994 
520 |a Hematopoietic Stem Cell Transplantation reviews pertinent aspects of both autologous and allogeneic stem cell transplantation and our current understanding of transplantation biology including T cell and natural killer cell biology, HLA expression, and post-transplant immune reconstitution. The unique aspect to this volume is that each chapter is co-authored by experts in their respective fields from different institutions to provide potentially different perspectives on each topic. This book provides a very current and succinct overview of hematopoietic stem cell transplantation that is complimentary to the larger texts on the field. "There have been dramatic advances in the application of hematopoietic stem cell transplantation for the treatment of malignant disease. This text provides a comprehensive update of the progress in the field. Technical and therapeutic innovations are reviewed by a distinguished assemblage of talented investigators." Steven T. Rosen, M.D., Series Editor